Center for Anxiety & Depression

Center for Anxiety & Depression in Mercer Island, Washington offers Spravato esketamine, an FDA-approved medication used alongside an oral antidepressant for adults with treatment-resistant depression who have failed multiple prior treatments. Spravato is fast-acting and works differently from earlier antidepressants, with improvement sometimes seen within the first few treatments.

Spravato is administered by nasal spray in-office, twice weekly for the first four weeks, then once weekly for the next four weeks, with maintenance determined after the initial eight-week period. A two-hour monitoring period follows each dose, and patients need an escort since they cannot drive afterward.

The practice also offers NeuroStar TMS, vagus nerve stimulation, medication management, psychotherapy, and comprehensive treatment planning, with doctors drawing on a combined 60 years of research and clinical experience.